Amlodipine Oral Solution (Brillian Pharma)

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameAmlodipine Oral Solution (Brillian Pharma)
Drug Alias NameSdamlo
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionCoronary Artery Disease
Global Approved IndicationsHypertensionCoronary Artery Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/07/24
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBrillian Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesBrillian Pharma Inc
Inactive CompaniesN/A
Active IndicationsHypertensionCoronary Artery Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A